0 items USD 0.00Search
- Did you mean
- closed%spondylitis
Your search for "closing%spondylitis" gave back 4455 results.
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The global...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Non Receptor Tyrosine Protein Kinase TYK2 - Pipeline Review, H2 2019 Summary Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) pipeline...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
